Sfoglia per Rivista HAEMATOLOGICA
Identification of two novel mutations in the 5'-untranslated region of H-ferritin using denaturing high performance liquid chromatography scanning
2003-01-01 Cremonesi, L; Foglieni, B; Fermo, I; Cozzi, A; Paroni, R; Ruggeri, G; Belloli, S; Levi, S; Fargion, S; Ferrari, M; Arosio, Paolo
Imatinib in adult and elderly Ph+ ALL patients: preliminary results of the GIMEMA prospective study LAL0201.
2004-01-01 Vignetti, M; Fazi, P; Meloni, G; Chiarenza, A; Malagola, Michele; Fabbiano, F; Recchia, A; Kropp, Mg; Offidani, M; Palmieri, S; Cilloni, D; Torelli, G; Elia, L; Ribersani, M; Baccarani, M; Mandelli, F.
Imatinib mesylate as experimental therapy in systemic mastocytosis with D816V c-kit mutation but without FIP1L1-PDGFR-alpha fusion transcript.
2004-01-01 Rondoni, M; Malagola, Michele; Piccaluga, Pp; Gaitani, S; Soverini, S; Ottaviani, E; Rosti, G; Ricci, P; Testoni, N; Poerio, A; Grafone, T; De Vivo, A; Amabile, M; Bosi, C; Baccarani, M; Martinelli, G.
Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome.
2004-01-01 Martinelli, G; Malagola, Michele; Ottaviani, E; Rosti, G; Trabacchi, E; Baccarani, M.
Imatinib mesylate can induce molecular complete remission in idiopathic hypereosinophilic sindrome. A phase II multicentric Italian clinical trial.
2006-01-01 Rondoni, M; Cilloni, D; Ottaviani, E; Piccaluga, Pp; Malagola, Michele; Messa, F; Gottardi, E; Soverini, S; Merante, S; Alimena, G; Pane, F; Paolini, S; Rancati, F; Saglio, G; Baccarani, M; Martinelli, G.
Imatinib mesylate in the treatment of newly diagnosed or refractory /resistant c-kit positive AML. Results of an italian multicentric phase II study.
2005-01-01 Malagola, Michele; Piccaluga, Pp; Martinelli, G; Rondoni, M; Arpinati, M; Tazzari, Pl; Amabile, M; Ottaviani, E; Candoni, A; Fanin, R; Cilloni, D; Gottardi, E; Saglio, G; Bocchia, M; Lauria, F; Visani, G; Russo, Domenico; Baccarani, M.
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-kit positive acute myeloid leukemia. Results of an italian multicentric phase II study.
2007-01-01 Piccaluga, Pp; Martinelli, G; Malagola, Michele; Rondoni, M; Arpinati, M; Tazzari, Pl; Amabile, M; Ottavini, E; Fanin, R; Cilloni, D; Saglio, G; Lauria, F; Visani, G; Russo, Domenico; Baccarani, M.
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant kit positive acute myeloid leukemia. Results of an italian multicentric phase II study.
2007-01-01 Piccaluga, Pp; Malagola, Michele; Rondoni, M; Arpinati, M; Paolini, S; Candoni, A; Fanin, R; Messa, E; Pirrotta, Mt; Lauria, F; Visani, G; Rancati, F; Vinaccia, V; Russo, Domenico; Saglio, G; Baccarani, M; Martinelli, G.
Imatinib mesylate therapy is not effective in systemic mastocytosis with D816V c-kit mutation.
2005-01-01 Rondoni, M; Piccaluga, Pp; Poverini, S; Malagola, Michele; Amabile, M; Pileri, S; Baccarani, M; Martinelli, G.
Immunoassay for human serum hemojuvelin
2010-01-01 Brasse-Lagnel, Carole; Poli, Maura; Lesueur, Céline; Grandchamp, Bernard; Lavoinne, Alain; Beaumont, Carole; Bekri, Soumeya
Immunohistochemistry of HFE in the duodenum of C282Y homozygotes with antisera for recombinant HFE protein
2000-01-01 Zuccon, L.; Corsi, B.; Levi, S.; Mattioli, M.; Francanzani, A. L.; Corti, A.; Albertini, Alberto; Sampietro, M.; Fargion, S.; Arosio, Paolo
In vitro activity of tyrosine kinase, farnesyl transferase and AKT kinase inhibitors on c-kit positive/negative and ;DR-pgp positive/negative leukaemia tumor cell lines.
2007-01-01 Malagola, Michele; Damiani, D; Michelutti, A; Martinelli, G; Ottaviani, E; Paolini, S; Piccaluga, Pp; Skert, C; Roccaro, A; Peli, A; Capuzzi, E; Filì, C; Bergonzi, C; Tiribelli, M; Fanin, R; Baccarani, M; Russo, Domenico
In vitro activity of tyrosine kinase, farnesyl transferase and akt kinase inhibitors on c-kit positive/negative and mdr-pgp positive/negative leukaemia tumor cell lines.
2007-01-01 Malagola, Michele; Damiani, D; Michelutti, A; Martinelli, G; Ottavini, E; Paolini, S; Piccaluga, Pp; Skert, C; Roccaro, A; Peli, A; Capuzzi, E; Fil, C; Bergonzi, C; Fanin, R; Baccarani, M; Russo, Domenico
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF)
2019-01-01 Farina, M; Bernardi, S; D'Adda, M; Foroni, C; Zanaglio, C; Dunbar, A; Re, F; Cattina, F; Rambaldi, B; Zollner, T; Turra, A; Morello, E; Malagola, M; Levine, Rl; Rossi, G; Polverelli, N; Russo, D
Incidence of bacterial and fungal infections in acute myeloid leukemia patients treated with induction regimens including fludarabine: a retrospective analysis of 224 cases
2008-01-01 Malagola, Michele; Peli, A; Damiani, D; Candoni, A; Tiribelli, M; Martinelli, G; Piccaluga PP3 Paolini, S; Lauria, F; Bocchia, M; Gobbi, M; Pierri, I; Zaccaria, A; Zuffa, E; Mazza, P; Piccolo, G; Gugliotta, L; Bovini, A; Visani, G; Skert, C; Bergonzi, C; Roccaro, A; Filì, C; Capuzzi, E; Fanin, R; Baccarani, M; Russo, Domenico
Induction intensified regimens includine fludarabine or gemtuzumab ozogamicin for AML patients: comparison by response and follow up.
2009-01-01 Papayannidis, C; Candoni, A; Paolini, S; Ottaviani, E; Iacobucci, I; Rondoni, M; Malagola, Michele; Piccaluga, Pp; Fanin, R; Visani, G; Baccarani, M; Russo, Domenico; Martinelli, G.
Influence of additional chromosome abnormalities to PH on response to imatinib mesylate therapy in early chronic phase in chronic myeloid leukemia
2008-01-01 Luatti, S; 1 Marzocchi, G; 1 Castagnetti, F; 1 Gamberini, C; 1 Baldazzi, C; 1 Stacchini, M; 1 Poerio, A; 1 Zaccaria, A; 2 Zanatta, L; 3 Giugliano, E; 4 Santulli, B; 5 Grimoldi, Mg; 6 Gozzetti, A; 7 Dalsass, A; Piovani, Giovanna; 9 Manna, M; 10 Modaferri, B; 11 Bernardi, F; 12 Bernasconi, P; 13 Kerim, S; 14 Abruzzese, E; 15 Palka, G; 16 Palandri, F; 1 Martinelli, G; 1 Rosti, G; 1 § Baccarani, M; 1 Testoni, N1
Intensive polychemotherapy experience in chronic myeloid leukemia
1989-01-01 Centurioni, R.; Leoni, P.; Russo, Domenico; Brianzoni, M. F.; Montillo, M.; Baccarani, M.; Tura, S.
Intermittent Imatinib (INTERIM) Treatment in Ph+-CML elderly patients in stable Complete Cytogenetic Response.
2012-01-01 Russo, Domenico; Martinelli, G.; Malagola, Michele; Cancelli, V; Zedda, S; Skert, C.; S., S. o. v. e. r. i. n. i.; Iacobucci, I.; Turri, D.; Mirto, S.; Gobbi, M; Pierri, I.; Vitolo, U.; Pregno, P.; Fogli, M.; Testoni, N.; De Vivo, A.; Castagnetti, F.; Morra, E.; Pungolino, E.; Di Raimondo, F.; Stagno, F.; Alimena, G.; Breccia, M.; Nobile, F.; Martino, B; Rambaldi, R.; Intermesoli, T; Saglio, G.; Rege Cambrin, G.; Visani, G.; Nicolini, G.; De Fabritiis, P.; Abruzzese, E.; Fanin, R.; Tiribelli, M.; Galieni, P.; Bigazzi, C.; Specchia, G.; Angelucci, E.; Usala, E.; Musolino, C.; Russo, S.; Gaidano, G.; Lunghi, M.; Lauria, F.; Bocchia, M.; Rodeghiero, F.; D’Emilio, A.; Bosi, A.; Santini, V.; Quarta, G.; Girasoli, M.; Fioritoni, G.; Di Lorenzo, R.; Cesana, Bruno Mario; Rosti, G; Baccarani, M.
INTRA BONE MARROW TRANSPLANTATION OF UMBILICAL CORD BLOOD HEMATOPOIETIC STEM CELL: A REPORT OF TWO CASES.
2010-01-01 Turra, A; Bergonzi, C; Skert, C; Malagola, Michele; Filì, C; Peli, A; Cattina, F; Colombi, C; Russo, Domenico
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Identification of two novel mutations in the 5'-untranslated region of H-ferritin using denaturing high performance liquid chromatography scanning | 1-gen-2003 | Cremonesi, L; Foglieni, B; Fermo, I; Cozzi, A; Paroni, R; Ruggeri, G; Belloli, S; Levi, S; Fargion, S; Ferrari, M; Arosio, Paolo | |
| Imatinib in adult and elderly Ph+ ALL patients: preliminary results of the GIMEMA prospective study LAL0201. | 1-gen-2004 | Vignetti, M; Fazi, P; Meloni, G; Chiarenza, A; Malagola, Michele; Fabbiano, F; Recchia, A; Kropp, Mg; Offidani, M; Palmieri, S; Cilloni, D; Torelli, G; Elia, L; Ribersani, M; Baccarani, M; Mandelli, F. | |
| Imatinib mesylate as experimental therapy in systemic mastocytosis with D816V c-kit mutation but without FIP1L1-PDGFR-alpha fusion transcript. | 1-gen-2004 | Rondoni, M; Malagola, Michele; Piccaluga, Pp; Gaitani, S; Soverini, S; Ottaviani, E; Rosti, G; Ricci, P; Testoni, N; Poerio, A; Grafone, T; De Vivo, A; Amabile, M; Bosi, C; Baccarani, M; Martinelli, G. | |
| Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome. | 1-gen-2004 | Martinelli, G; Malagola, Michele; Ottaviani, E; Rosti, G; Trabacchi, E; Baccarani, M. | |
| Imatinib mesylate can induce molecular complete remission in idiopathic hypereosinophilic sindrome. A phase II multicentric Italian clinical trial. | 1-gen-2006 | Rondoni, M; Cilloni, D; Ottaviani, E; Piccaluga, Pp; Malagola, Michele; Messa, F; Gottardi, E; Soverini, S; Merante, S; Alimena, G; Pane, F; Paolini, S; Rancati, F; Saglio, G; Baccarani, M; Martinelli, G. | |
| Imatinib mesylate in the treatment of newly diagnosed or refractory /resistant c-kit positive AML. Results of an italian multicentric phase II study. | 1-gen-2005 | Malagola, Michele; Piccaluga, Pp; Martinelli, G; Rondoni, M; Arpinati, M; Tazzari, Pl; Amabile, M; Ottaviani, E; Candoni, A; Fanin, R; Cilloni, D; Gottardi, E; Saglio, G; Bocchia, M; Lauria, F; Visani, G; Russo, Domenico; Baccarani, M. | |
| Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-kit positive acute myeloid leukemia. Results of an italian multicentric phase II study. | 1-gen-2007 | Piccaluga, Pp; Martinelli, G; Malagola, Michele; Rondoni, M; Arpinati, M; Tazzari, Pl; Amabile, M; Ottavini, E; Fanin, R; Cilloni, D; Saglio, G; Lauria, F; Visani, G; Russo, Domenico; Baccarani, M. | |
| Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant kit positive acute myeloid leukemia. Results of an italian multicentric phase II study. | 1-gen-2007 | Piccaluga, Pp; Malagola, Michele; Rondoni, M; Arpinati, M; Paolini, S; Candoni, A; Fanin, R; Messa, E; Pirrotta, Mt; Lauria, F; Visani, G; Rancati, F; Vinaccia, V; Russo, Domenico; Saglio, G; Baccarani, M; Martinelli, G. | |
| Imatinib mesylate therapy is not effective in systemic mastocytosis with D816V c-kit mutation. | 1-gen-2005 | Rondoni, M; Piccaluga, Pp; Poverini, S; Malagola, Michele; Amabile, M; Pileri, S; Baccarani, M; Martinelli, G. | |
| Immunoassay for human serum hemojuvelin | 1-gen-2010 | Brasse-Lagnel, Carole; Poli, Maura; Lesueur, Céline; Grandchamp, Bernard; Lavoinne, Alain; Beaumont, Carole; Bekri, Soumeya | |
| Immunohistochemistry of HFE in the duodenum of C282Y homozygotes with antisera for recombinant HFE protein | 1-gen-2000 | Zuccon, L.; Corsi, B.; Levi, S.; Mattioli, M.; Francanzani, A. L.; Corti, A.; Albertini, Alberto; Sampietro, M.; Fargion, S.; Arosio, Paolo | |
| In vitro activity of tyrosine kinase, farnesyl transferase and AKT kinase inhibitors on c-kit positive/negative and ;DR-pgp positive/negative leukaemia tumor cell lines. | 1-gen-2007 | Malagola, Michele; Damiani, D; Michelutti, A; Martinelli, G; Ottaviani, E; Paolini, S; Piccaluga, Pp; Skert, C; Roccaro, A; Peli, A; Capuzzi, E; Filì, C; Bergonzi, C; Tiribelli, M; Fanin, R; Baccarani, M; Russo, Domenico | |
| In vitro activity of tyrosine kinase, farnesyl transferase and akt kinase inhibitors on c-kit positive/negative and mdr-pgp positive/negative leukaemia tumor cell lines. | 1-gen-2007 | Malagola, Michele; Damiani, D; Michelutti, A; Martinelli, G; Ottavini, E; Paolini, S; Piccaluga, Pp; Skert, C; Roccaro, A; Peli, A; Capuzzi, E; Fil, C; Bergonzi, C; Fanin, R; Baccarani, M; Russo, Domenico | |
| IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) | 1-gen-2019 | Farina, M; Bernardi, S; D'Adda, M; Foroni, C; Zanaglio, C; Dunbar, A; Re, F; Cattina, F; Rambaldi, B; Zollner, T; Turra, A; Morello, E; Malagola, M; Levine, Rl; Rossi, G; Polverelli, N; Russo, D | |
| Incidence of bacterial and fungal infections in acute myeloid leukemia patients treated with induction regimens including fludarabine: a retrospective analysis of 224 cases | 1-gen-2008 | Malagola, Michele; Peli, A; Damiani, D; Candoni, A; Tiribelli, M; Martinelli, G; Piccaluga PP3 Paolini, S; Lauria, F; Bocchia, M; Gobbi, M; Pierri, I; Zaccaria, A; Zuffa, E; Mazza, P; Piccolo, G; Gugliotta, L; Bovini, A; Visani, G; Skert, C; Bergonzi, C; Roccaro, A; Filì, C; Capuzzi, E; Fanin, R; Baccarani, M; Russo, Domenico | |
| Induction intensified regimens includine fludarabine or gemtuzumab ozogamicin for AML patients: comparison by response and follow up. | 1-gen-2009 | Papayannidis, C; Candoni, A; Paolini, S; Ottaviani, E; Iacobucci, I; Rondoni, M; Malagola, Michele; Piccaluga, Pp; Fanin, R; Visani, G; Baccarani, M; Russo, Domenico; Martinelli, G. | |
| Influence of additional chromosome abnormalities to PH on response to imatinib mesylate therapy in early chronic phase in chronic myeloid leukemia | 1-gen-2008 | Luatti, S; 1 Marzocchi, G; 1 Castagnetti, F; 1 Gamberini, C; 1 Baldazzi, C; 1 Stacchini, M; 1 Poerio, A; 1 Zaccaria, A; 2 Zanatta, L; 3 Giugliano, E; 4 Santulli, B; 5 Grimoldi, Mg; 6 Gozzetti, A; 7 Dalsass, A; Piovani, Giovanna; 9 Manna, M; 10 Modaferri, B; 11 Bernardi, F; 12 Bernasconi, P; 13 Kerim, S; 14 Abruzzese, E; 15 Palka, G; 16 Palandri, F; 1 Martinelli, G; 1 Rosti, G; 1 § Baccarani, M; 1 Testoni, N1 | |
| Intensive polychemotherapy experience in chronic myeloid leukemia | 1-gen-1989 | Centurioni, R.; Leoni, P.; Russo, Domenico; Brianzoni, M. F.; Montillo, M.; Baccarani, M.; Tura, S. | |
| Intermittent Imatinib (INTERIM) Treatment in Ph+-CML elderly patients in stable Complete Cytogenetic Response. | 1-gen-2012 | Russo, Domenico; Martinelli, G.; Malagola, Michele; Cancelli, V; Zedda, S; Skert, C.; S., S. o. v. e. r. i. n. i.; Iacobucci, I.; Turri, D.; Mirto, S.; Gobbi, M; Pierri, I.; Vitolo, U.; Pregno, P.; Fogli, M.; Testoni, N.; De Vivo, A.; Castagnetti, F.; Morra, E.; Pungolino, E.; Di Raimondo, F.; Stagno, F.; Alimena, G.; Breccia, M.; Nobile, F.; Martino, B; Rambaldi, R.; Intermesoli, T; Saglio, G.; Rege Cambrin, G.; Visani, G.; Nicolini, G.; De Fabritiis, P.; Abruzzese, E.; Fanin, R.; Tiribelli, M.; Galieni, P.; Bigazzi, C.; Specchia, G.; Angelucci, E.; Usala, E.; Musolino, C.; Russo, S.; Gaidano, G.; Lunghi, M.; Lauria, F.; Bocchia, M.; Rodeghiero, F.; D’Emilio, A.; Bosi, A.; Santini, V.; Quarta, G.; Girasoli, M.; Fioritoni, G.; Di Lorenzo, R.; Cesana, Bruno Mario; Rosti, G; Baccarani, M. | |
| INTRA BONE MARROW TRANSPLANTATION OF UMBILICAL CORD BLOOD HEMATOPOIETIC STEM CELL: A REPORT OF TWO CASES. | 1-gen-2010 | Turra, A; Bergonzi, C; Skert, C; Malagola, Michele; Filì, C; Peli, A; Cattina, F; Colombi, C; Russo, Domenico |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile